Cargando…
Utilization of Genomic Signatures to Identify Phenotype-Specific Drugs
Genetic and genomic studies highlight the substantial complexity and heterogeneity of human cancers and emphasize the general lack of therapeutics that can match this complexity. With the goal of expanding opportunities for drug discovery, we describe an approach that makes use of a phenotype-based...
Autores principales: | Mori, Seiichi, Chang, Jeffrey T., Andrechek, Eran R., Potti, Anil, Nevins, Joseph R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729377/ https://www.ncbi.nlm.nih.gov/pubmed/19714244 http://dx.doi.org/10.1371/journal.pone.0006772 |
Ejemplares similares
-
Mouse models of cancers: opportunities to address heterogeneity of human cancer and evaluate therapeutic strategies
por: Andrechek, Eran R., et al.
Publicado: (2010) -
A Role for E2F Activities in Determining the Fate of Myc-Induced Lymphomagenesis
por: Rempel, Rachel E., et al.
Publicado: (2009) -
SIGNATURE: A workbench for gene expression signature analysis
por: Chang, Jeffrey T, et al.
Publicado: (2011) -
HER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors
por: Andrechek, Eran R.
Publicado: (2013) -
Low E2F2 activity is associated with high genomic instability and PARPi resistance
por: Rennhack, Jonathan P., et al.
Publicado: (2020)